Literature DB >> 10440876

Defining an international research agenda for quality of life in men with prostate cancer.

M S Litwin1, J M Fitzpatrick, S D Fossa, D W Newling.   

Abstract

BACKGROUND: While the traditional goal in the management of patients with prostate cancer has been to maximize survival, the recent advent of the medical outcomes movement has underscored the importance of patient-centered issues, such as health-related quality of life (HRQOL).
METHODS: In this paper we present a comprehensive approach to the study of HRQOL in men with prostate cancer. We begin by defining HRQOL in general, discussing its measurement, and placing it in the context of prostate cancer. We then describe the primary goals of HRQOL research and present examples of validated instruments. We finish by proposing a quality of life research agenda for the next two decades.
RESULTS: Contemporary perspectives on HRQOL are based on the World Health Organization's definition of health as not merely the absence of disease, but as a state of physical, emotional, and social well-being. HRQOL measurement must adhere to the strict methodological principles of survey psychometrics and is best accomplished with any of several validated instruments. Once collected, HRQOL information is useful for prostate cancer patients facing difficult treatment decisions.
CONCLUSIONS: A solid foundation for HRQOL research has been built in early- and late-stage prostate cancer. It includes the development of new instruments and the establishment of descriptive data. This groundwork will allow investigators to address more complex research issues, such as interpreting interactions among HRQOL domains, presenting HRQOL data to future patients, optimally timing HRQOL data collection, uncovering innate and alterable factors that influence HRQOL, and exploring the intercultural nuances of HRQOL assessment. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10440876     DOI: 10.1002/(sici)1097-0045(19990915)41:1<58::aid-pros8>3.0.co;2-3

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  The relationship of quality of life and distress in prostate cancer patients compared to the general population.

Authors:  Markus Zenger; Antje Lehmann-Laue; Jens-Uwe Stolzenburg; Thilo Schwalenberg; Alexander Ried; Andreas Hinz
Journal:  Psychosoc Med       Date:  2010-06-30

2.  A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life.

Authors:  G van Andel; P Fernandez de Moral; C T M Caris; P Carpentier; J Wils; M J F M de Bruin; J A Witjes; F M J Debruyne; W P J Witjes
Journal:  World J Urol       Date:  2003-06-18       Impact factor: 4.226

3.  Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.

Authors:  Irene M Lips; Uulke A van der Heide; Karin Haustermans; Emile N J T van Lin; Floris Pos; Stefan P G Franken; Alexis N T J Kotte; Carla H van Gils; Marco van Vulpen
Journal:  Trials       Date:  2011-12-05       Impact factor: 2.279

Review 4.  Sexual quality of life for localized prostate cancer: a cross-cultural study between Japanese and American men.

Authors:  Shunichi Namiki; Yoichi Arai
Journal:  Reprod Med Biol       Date:  2011-02-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.